Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Identification and Treatment of Depression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00863200
Recruitment Status : Completed
First Posted : March 17, 2009
Last Update Posted : May 28, 2019
Sponsor:
Collaborator:
Robert Wood Johnson Foundation
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

Brief Summary:
The goal of this research study is to learn how well a telephone system works for improving the management of emotional distress, sadness, and/or depression in patients who are being treated for cancer.

Condition or disease Intervention/treatment
Cancer Behavioral: Telephone Intervention Behavioral: Questionnaires & Interviews

Show Show detailed description

Layout table for study information
Study Type : Observational
Actual Enrollment : 134 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Identification and Treatment of Depression in Underserved African American and Latino Patients With Cancer
Actual Study Start Date : March 2009
Actual Primary Completion Date : February 12, 2019
Actual Study Completion Date : February 12, 2019

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Telephone Intervention Group Behavioral: Telephone Intervention
Symptom information will be collected using an automated telephone system, approximately 5 minutes per week.
Other Names:
  • Interactive voice response
  • IVR

Behavioral: Questionnaires & Interviews
3 questionnaires and one-on-one interviews during 3 regularly scheduled clinic visits.
Other Name: Survey

Standard Care Group Behavioral: Questionnaires & Interviews
3 questionnaires and one-on-one interviews during 3 regularly scheduled clinic visits.
Other Name: Survey




Primary Outcome Measures :
  1. Learn how well a telephone system works for improving the management of emotional distress, sadness, and/or depression in patients who are being treated for cancer. [ Time Frame: 3 Years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
African American or Hispanics over 18 years of age being treated for cancer at LBJ General Hospital in Houston.
Criteria

Inclusion Criteria:

  1. Diagnosis of cancer
  2. Self-identified as African American or Latino
  3. English or Spanish speaking
  4. 18 years of age or older
  5. Receiving treatment in the medical oncology, genitourinary oncology, or gynecologic oncology clinics at LBJ General Hospital
  6. Reports a level of "4" or greater on the MDASI "sadness" and/or "distress" items.

Exclusion Criteria:

1) Not willing to use a telephone to report symptoms.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00863200


Locations
Layout table for location information
United States, Texas
LBJ General Hospital
Houston, Texas, United States, 77030
Sponsors and Collaborators
M.D. Anderson Cancer Center
Robert Wood Johnson Foundation
Investigators
Layout table for investigator information
Principal Investigator: Tito Mendoza, BS,MED,MS,PHD M.D. Anderson Cancer Center
Additional Information:
Layout table for additonal information
Responsible Party: M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier: NCT00863200    
Other Study ID Numbers: 2008-0327
First Posted: March 17, 2009    Key Record Dates
Last Update Posted: May 28, 2019
Last Verified: May 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by M.D. Anderson Cancer Center:
Depression
Cancer
African Americans
Latinos
Hispanics
Interactive voice response
IVR
Behavioral Intervention
Additional relevant MeSH terms:
Layout table for MeSH terms
Depression
Behavioral Symptoms